pembrolizumab
merck
['pembro', 'keynote-716', 'key,note,716']
jason luke, md, facp, recently presented new long-term data of distant-metastasis-free survival from the keynote-716 #pembrolizumab clinical trial at the 2023 american society of clinical oncology (asco) meeting. 
Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products, and drugs.